Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

InfoDesk Releases PipelinePlus 2.0 Pharmaceutical Intelligence Platform
  • USA - English


News provided by

InfoDesk

Jan 08, 2016, 20:00 ET

Share this article

Share toX

Share this article

Share toX

PipelinePlus 2.0 makes sharing your drug pipeline research as easy as 1-2-3
PipelinePlus 2.0 makes sharing your drug pipeline research as easy as 1-2-3

PipelinePlus 2.0 is literally so powerful, it can do complex, cross-database drug pipeline searches that once took days, in a matter of minutes.

Post this

Tarrytown, NY (PRWEB) January 08, 2016 -- InfoDesk has released a new and more powerful version of PipelinePlus, its pharmaceutical intelligence platform that dramatically simplifies drug pipeline research, monitoring and sharing. The new version, PipelinePlus 2.0, offers a sleek new redesign with many new product features and updates to enhance searching, building or modifying queries, managing search results and exporting. Additionally, the new version exports to Excel, creates customized reports, generates funnel chart visualizations and exports easily to BizInt Smart Charts for Drug Pipelines.

“We are very excited about all the enhancements in the new version of PipelinePlus,” said Sterling Stites, InfoDesk CEO. “Not only does the new interface look great—it’s easier to use.” What’s more, Stites said, “PipelinePlus 2.0 is literally so powerful, it can do complex, cross-database drug pipeline searches that once took days, in a matter of minutes.” No doubt, he added, pharmaceutical executives, researchers and investors “will immediately recognize the value of this powerful new tool.”

Download the new PipelinePlus 2.0 fact sheet.

PipelinePlus was developed by InfoDesk to simplify drug pipeline searching by mapping the key taxonomies of four well-known databases and providing instantly federated results and related drug news on a single, easy-to-use platform. PipelinePlus 2.0, with its redesigned user interface, greatly enhances all these features.

About PipelinePlus 2.0

Bonnie Snow, Director of InfoDesk Pharma Intelligence, and her team have worked on the new PipelinePlus 2.0 release for the past year. “Much is of this work has been behind-the-scenes, highly detailed taxonomy mapping to ensure the most accurate search results,” said Stites.

Among the more visible improvements, the most noteworthy are its simplified query builder, enhanced results viewing and expanded export options, including funnel chart visualizations and ability to export to BizInt SmartCharts.

Simplified Query Building

Depending on the complexity of the drug development search, query building can be very complex, requiring multiple criteria, including Boolean operators such as “AND, OR and NOT.” PipelinePlus 2.0 features a new query builder that enables the user to create and modify complex queries, much more easily. Furthermore, the new version provides more search options, such as the ability to search by record update date, drug class hierarchy, mechanism of action and associated company, (e.g., licensees, collaborators), in addition to the company tied to the development phase and more.

Enhanced Results Viewing

Another critical part of the new PipelinePlus 2.0 interface is its enhanced results page. The redesigned page makes it easier to view, expand and collapse search results, including the ability to view full direct records with a single click.

Funnel Chart Visualizations

Perhaps one of the most outstanding new features of PipelinePlus 2.0 is its unique ability to easily create, maintain and update drug pipeline visualization funnel charts. This is not just a huge time-saver for companies that need to track multiple drugs and therapeutic categories; it can also amount to substantial cost savings. Further, the ability to create funnel charts quickly and easily for presentations can speed the decision making process.

Exporting to BizInt Smart Charts

For many years, experienced information analysts have relied on BizInt Smart Charts software to create, customize and distribute competitive intelligence reports and visualizations from drug pipeline databases. BizInt Solutions, Inc. has added support for data exported from PipelinePlus 2.0 to its new BizInt Smart Charts for Drug Pipelines 4.1 software. “This collaboration is a major plus for BizInt and PipelinePlus users alike, “ Said Stites. “Now they can get all the power of PipelinePlus, output directly in any of their preferred Smart Chart formats.”

To introduce PipelinePlus 2.0, InfoDesk will offer online demos, fact sheets and introductory pricing to qualified prospects. For more information about PipelinePlus 2.0, contact info(at)infodesk.com or call 914.332.5940 (US) or +44 (0) 7712 707376 (UK).

About InfoDesk

InfoDesk specializes in information management and content curation solutions that help organizations integrate, deliver and share content resources more quickly, cost effectively and securely. For more than 16 years InfoDesk has helped some of the largest multinational corporations, top government agencies and media companies maximize their information resources. InfoDesk is based in Tarrytown, NY with offices in London and Washington DC.

About BizInt Smart Charts

BizInt Solutions, Inc. develops BizInt Smart Charts software to help information analysts create, customize and distribute competitive intelligence reports and visualizations from drug pipeline, clinical trial, patent and IP sequence databases. The BizInt Smart Charts product family is used by pharmaceutical, biotech, chemical and device/diagnostics companies worldwide to support product lifecycle planning and portfolio management.

Sean Smith, InfoDesk, http://www.infodesk.com, +1 (914) 798-2432, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.